Lethal Very Long-Chain Acyl-Coa Dehydrogenase Deficiency with a Novel Mutation
Abstract
Very long chain acyl-CoA dehydrogenase deficiency is an autosomal recessive genetic disorder in which the first step in the mitochondrial β-oxidation of fatty acids for 14-20 carbons is defective. Clinical presentation is heterogeneous ranging from the severe neonatal form presenting with hypo-ketotic hypoglycemia, liver dysfunction and rapidly fatal cardiomyopathy with episodes of hypo-ketotic hypoglycemia in infants. Herein we report a patient with novel homozygous missense mutation c.1391C>A in exon 14 with a severe neonatal onset type who presented with hypoketotic hypoglycemia, cardiomyopathy and hepatomegaly.References
Schiff M, Mohsen AW, Karunanidhi A, McCracken E, Yeasted R, Vockley J. Molecular and cellular pathology of very-long-chain acyl-Co Adehydrogenase deficiency. Mol Genet Metab. 2013;109(1):21-7.
Spiekerkoetter U, Mueller M, Sturm M, Hofmann M, Schneider DT. Lethal Undiagnosed Very Long-ChainAcyl-CoA Dehydrogenase Deficiency with Mild C14-Acylcarnitine Abnormalities on Newborn Screening. JIMD Rep. 2012;6:113-5.
Siu WK, Mak CM, Siu SL, Siu TS, Pang CY, Lam CW, Kwong NS, Chan AY. Molecular diagnosis for a fatal case of very long-chain acyl-CoA dehydrogenase deficiency in Hong Kong Chinese with a novel mutation: a preventable death by newbornscreening. Diagn Mol Pathol. 2012;21(3):184-7.
Pervaiz MA, Kendal F, Hegde M, Singh RH. MCT oil-based diet reverses hypertrophic cardiomyopathy in a patient with very long chain acyl-coA dehydrogenase deficiency. Indian J Hum Genet. 2011;17(1):29-32.
Eminoglu TF, Tumer L, Okur I, Ezgu FS, Biberoglu G, Hasanoglu A. Verylong-chain acyl CoA dehydrogenase deficiency which was accepted as infanticide. Forensic Sci Int. 2011;210(1-3):e1-3.
McGoey RR, Marble M. Positive newborn screen in a normal infant of a mother with asymptomatic verylong-chainAcyl-CoA dehydrogenase deficiency. J Pediatr. 2011;158(6):1031-2.
Vellekoop P, Diekman EF, vanTuijl I, de Vries MM, vanHasselt PM, VisserG. Perioperative measures in very long chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab. 2011;103(1):96-7.
Mendez-Figueroa H, Shchelochkov OA, Shaibani A, Aagaard-Tillery K, ShinawiMS. Clinical and biochemical improvement of very long-chain acyl-CoA dehydrogenase deficiency in pregnancy. J Perinatol. 2010;30(8):558-62.
Coughlin CR 2nd, Ficicioglu C. Genotype-phenotype correlations: sudden death in an infant with very-long-chain acyl-CoAdehydrogenase deficiency. J Inherit Metab Dis. 2010;33 Suppl 3:S129-31. Ficicioglu C, Coughlin CR 2nd, Bennett MJ, Yudkoff M. Verylong-chain acyl-CoA dehydrogenas edeficiency in a patient with normal newborn screening by tandem mass spectrometry. J Pediatr. 2010;156(3):492-4.
Aliefendioğlu D, Dursun A, Coşkun T, Akçören Z, Wanders RJ, Waterham HR. A newborn with VLCAD deficiency. Clinical, biochemical, and histopathological findings. Eur J Pediatr. 2007;166(10):1077-80.
Merinero B, Alcaide P, Martín-Hernández E, Morais A, García-Silva MT,Quijada-Fraile P, Pedrón-Giner C, Dulin E, Yahyaoui R, Egea JM, Belanger-Quintana A, Blasco-Alonso J, FernandezRuano ML, Besga B, Ferrer-López I, Leal F, Ugarte M, Ruiz-Sala P, Pérez B, Pérez-Cerdá C. FourYears' Experience in the Diagnosis of Very Long-ChainAcyl-CoA Dehydrogenase Deficiency in Infants Detected in Three Spanish Newborn Screening Centers. JIMD Rep. 2018;39:63-74.
Katz S, Landau Y, Pode-Shakked B, Pessach IM, Rubinshtein M, Anikster Y, Salem Y, Paret G. Cardiac failure in very long chain acyl-CoA dehydrogenase deficiency requiring extracorporeal membrane oxygenation (ECMO) treatment: A case report and review of the literature. Mol Genet Metab Rep. 2016;10:5-7.
